By Tiffany Hu ( June 21, 2021, 8:06 PM EDT) -- The full Federal Circuit on Monday refused to revisit a decision that invalidated two of Amgen's patents on its cholesterol medication Repatha, though a panel of judges disputed the drugmaker's "sky is falling" approach in arguing that the ruling changed the law....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.